Biomedical Advanced Research
and Development Authority (BARDA)
Subscribe to RSS: 
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.
The mission of the Biomedical Advanced Research and Development Authority (BARDA) is to develop and procure medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases. Specifically, BARDA supports the advanced development and procurement of drugs, vaccines and other products that are considered priorities for national health security through its programmatic initiatives.
BARDA funding and acquisitions bridge the "valley of death" characterizing the late stages of product development. BARDA's support ensures continuity of funding for medical countermeasures developed by industry or emerging from the basic research and preclinical development activities sponsored by the National Institutes of Health (NIH). In procuring medical countermeasures for the Strategic National Stockpile, BARDA enhances the capabilities of the Centers for Disease Control and Prevention (CDC) to organize an effective response.
BARDA manages Project BioShield, which includes the procurement and advanced development of medical countermeasures for chemical, biological, radiological, and nuclear agents, as well as the advanced development and procurement of medical countermeasures for pandemic influenza and other emerging infectious diseases that fall outside the auspices of Project BioShield. In addition, BARDA manages the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) and is a key partner in implementing the PHEMCE strategies.
To learn more about requirements setting for medical countermeasure research and development click here.
Newsroom
- Now open: Broad Agency Announcements
- February 8, 2013
BARDA Fill-Finish Manufacturing Network Solicitation posted - January 23, 2013
BARDA Fill-Finish Manufacturing Network synopsis posted - January 17, 2013
Statement from Assistant Secretary Nicole Lurie on FDA approval of new influenza vaccine manufactured with novel technology
Popular Resources
Centers for Innovation in Advanced Development and Manufacturing
- Webcast Announcement: HHS creates new centers to develop, manufacture medical countermeasures
- HHS Creates New Centers
- Centers for Innovation in Advanced Development and Manufacturing (CIADM) Fact Sheet
Industry partners are encouraged to visit the BARDA BAA and sign up for a TechWatch meeting.
